United Therapeutics Corp Share Price
NASDAQ: UTHRHealthcare
Live United Therapeutics Corp Share Price Chart
O H L
United Therapeutics Corp Performance Overview
Days Range
▼
$493.00Low
$498.00High
Markets Today
| Previous Close | $497.27 |
|---|---|
| Open | $495.47 |
| Volume | 108,823 |
| Day's Range | $493.00 - $498.00 |
| 52W Range | $397.97 - $609.35 |
| Market Cap | $21.38 B |
Historical Performance
| 1M Returns | -4.05 |
|---|---|
| 3M Returns | -7.33 |
| 6M Returns | -6.24 |
| 1Y Returns | +21.32 |
| 5Y Returns | +148.54 |
| 10Y Returns | +305.07 |
United Therapeutics Corp Fundamentals
| Market Cap | $21.38 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 17.83 |
| PEG Ratio | N/A |
| Revenue | $3.18 B |
| ROE TTM | 0.20 |
| EPS TTM | $27.96 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.32 |
| EBITDA | $1.58 B |
| Profit Margin | 41.94 |
| Market Cap | $21.38 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 17.83 |
| PEG Ratio | N/A |
| Revenue | $3.18 B |
| ROE TTM | 0.20 |
| EPS TTM | $27.96 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.32 |
| EBITDA | $1.58 B |
| Profit Margin | 41.94 |
United Therapeutics Corp Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $794.40 M | $798.60 M | $799.50 M | $790.20 M | $781.50 M | $783.30 M |
| Gross Profit + | $701.90 M | $711.00 M | $698.60 M | $686.80 M | $648.10 M | $683.80 M |
| Operating Income | $382.80 M | $364.50 M | $388.50 M | $356.70 M | $325.80 M | $330.80 M |
| EBITDA | $402.60 M | $385.60 M | $410.40 M | $379.50 M | $348.40 M | $355.00 M |
| Interest Expense | -$6.10 M | -$7.30 M | -$3.00 M | -$3.10 M | -$3.00 M | -$2.90 M |
| Depreciation | $19.80 M | $21.10 M | $21.90 M | $22.80 M | $22.60 M | $24.20 M |
| Income Before Tax | $423.50 M | $408.40 M | $438.00 M | $444.00 M | $318.30 M | $372.70 M |
| Income Tax Expense | $101.30 M | $98.90 M | $99.30 M | $79.70 M | $43.40 M | $39.70 M |
| Net Income + | $322.20 M | $309.50 M | $338.70 M | $364.30 M | $274.90 M | $333.00 M |
| Net Profit Margin | 40.56% | 38.76% | 42.36% | 46.1% | 35.18% | 42.51% |
United Therapeutics Corp Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $800.00 K | $800.00 K | $800.00 K | $800.00 K | $800.00 K | $800.00 K |
| Reserve & Surplus | $7.54 B | $7.85 B | $8.19 B | $8.56 B | $8.82 B | $9.15 B |
| Non-Current Liabilities | $215.20 M | $207.30 M | $214.60 M | $223.20 M | $214.00 M | $212.00 M |
| Current Liabilities | $721.50 M | $527.10 M | $546.30 M | $560.60 M | $599.10 M | $607.80 M |
| Total Liabilities | $936.70 M | $734.40 M | $760.90 M | $783.80 M | $813.10 M | $819.80 M |
| Fixed Assets | $1.41 B | $1.47 B | $1.67 B | $1.85 B | $1.96 B | $2.04 B |
| Current Assets | $3.94 B | $3.83 B | $3.49 B | $3.70 B | $2.87 B | $3.48 B |
| Total Assets | $7.74 B | $7.91 B | $7.35 B | $7.88 B | $6.71 B | $7.22 B |
United Therapeutics Corp Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $322.20 M | $309.50 M | $338.70 M | $364.30 M | $274.90 M | $333.00 M |
| Operating Cash Flow | $461.20 M | $191.70 M | $562.10 M | $346.20 M | $463.30 M | $313.60 M |
| Investing Cash Flow | -$164.70 M | -$299.90 M | $140.90 M | -$227.60 M | $743.70 M | $87.50 M |
| Financing Cash Flow | -$93.80 M | -$198.60 M | -$956.00 M | $98.40 M | -$1.48 B | $122.40 M |
| Change in Cash | $202.70 M | -$306.80 M | -$253.00 M | $217.00 M | -$277.40 M | $523.50 M |
United Therapeutics Corp Return Calculator
The United Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$24,658
Invested Amount$10,000
Est. Returns$14,658
About United Therapeutics Corp
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
Popular Stocks
FAQs
What is the share price of United Therapeutics Corp today?
United Therapeutics Corp (UTHR) share price as of September 18, 2026 is $493.36. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of United Therapeutics Corp?
Yes, Indian Investors can invest in the United Therapeutics Corp (UTHR) Share by opening an international trading account with Angel One.
How can I purchase United Therapeutics Corp shares in India?
Purchasing United Therapeutics Corp (UTHR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying United Therapeutics Corp (UTHR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of United Therapeutics Corp?
Yes, you can purchase fractional shares of United Therapeutics Corp (UTHR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of United Therapeutics Corp?
The market capitalization of United Therapeutics Corp on September 18, 2026, is $21.38 B.
In which sector United Therapeutics Corp belongs?
United Therapeutics Corp operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in United Therapeutics Corp stocks?
In order to invest in United Therapeutics Corp (UTHR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
